Humanigen Inc (HGENQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Humanigen Net Income (Quarterly): -4.182M for March 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -4.182M |
| December 31, 2022 | 4.39M |
| September 30, 2022 | -23.69M |
| June 30, 2022 | -30.15M |
| March 31, 2022 | -21.28M |
| December 31, 2021 | -33.54M |
| September 30, 2021 | -66.74M |
| June 30, 2021 | -70.80M |
| March 31, 2021 | -65.57M |
| December 31, 2020 | -32.30M |
| September 30, 2020 | -30.75M |
| June 30, 2020 | -24.02M |
| March 31, 2020 | -2.467M |
| December 31, 2019 | -2.026M |
| September 30, 2019 | -2.389M |
| June 30, 2019 | -3.338M |
| March 31, 2019 | -2.541M |
| December 31, 2018 | -2.073M |
| September 30, 2018 | -2.176M |
| June 30, 2018 | -2.668M |
| March 31, 2018 | -5.087M |
| December 31, 2017 | -3.10M |
| September 30, 2017 | -7.185M |
| June 30, 2017 | -6.154M |
| Date | Value |
|---|---|
| March 31, 2017 | -5.548M |
| December 31, 2016 | -5.058M |
| September 30, 2016 | -4.523M |
| June 30, 2016 | -12.01M |
| March 31, 2016 | -5.426M |
| December 31, 2015 | -13.12M |
| September 30, 2015 | -6.60M |
| June 30, 2015 | -6.04M |
| March 31, 2015 | -9.622M |
| December 31, 2014 | -9.713M |
| September 30, 2014 | -8.063M |
| June 30, 2014 | -9.814M |
| March 31, 2014 | -10.41M |
| December 31, 2013 | -10.24M |
| September 30, 2013 | -11.33M |
| June 30, 2013 | -11.81M |
| March 31, 2013 | -8.574M |
| December 31, 2012 | -11.70M |
| September 30, 2012 | -8.602M |
| June 30, 2012 | -2.08M |
| March 31, 2012 | -1.131M |
| December 31, 2011 | 1.662M |
| September 30, 2011 | -0.976M |
| June 30, 2011 | -1.18M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-70.80M
Minimum
Jun 2021
4.39M
Maximum
Dec 2022
-25.55M
Average
-23.86M
Median
Net Income (Quarterly) Benchmarks
| Cannabis Global Inc | -0.4746M |
| Item 9 Labs Corp | -5.911M |
| Cantabio Pharmaceuticals Inc | 0.343M |
| Affymax Inc | -- |
| Statera BioPharma Inc | -3.349M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.221M |
| Total Expenses (Quarterly) | 4.456M |
| EPS Diluted (Quarterly) | -0.04 |
| Profit Margin (Quarterly) | -1.89K% |